AU2018262811B2 - Secretion-competent muteins of the human IL-27 alpha-subunit - Google Patents

Secretion-competent muteins of the human IL-27 alpha-subunit Download PDF

Info

Publication number
AU2018262811B2
AU2018262811B2 AU2018262811A AU2018262811A AU2018262811B2 AU 2018262811 B2 AU2018262811 B2 AU 2018262811B2 AU 2018262811 A AU2018262811 A AU 2018262811A AU 2018262811 A AU2018262811 A AU 2018262811A AU 2018262811 B2 AU2018262811 B2 AU 2018262811B2
Authority
AU
Australia
Prior art keywords
leu
arg
pro
subunit
ser
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
AU2018262811A
Other languages
English (en)
Other versions
AU2018262811A1 (en
Inventor
Matthias Feige
Stephanie Mueller
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Technische Universitaet Muenchen
Original Assignee
Technische Universitaet Muenchen
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Technische Universitaet Muenchen filed Critical Technische Universitaet Muenchen
Publication of AU2018262811A1 publication Critical patent/AU2018262811A1/en
Application granted granted Critical
Publication of AU2018262811B2 publication Critical patent/AU2018262811B2/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/54—Interleukins [IL]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/20—Fusion polypeptide containing a tag with affinity for a non-protein ligand
    • C07K2319/21—Fusion polypeptide containing a tag with affinity for a non-protein ligand containing a His-tag
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/50—Fusion polypeptide containing protease site

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Zoology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Transplantation (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Toxicology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AU2018262811A 2017-05-04 2018-05-04 Secretion-competent muteins of the human IL-27 alpha-subunit Active AU2018262811B2 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP17169358 2017-05-04
EP17169358.3 2017-05-04
PCT/EP2018/061561 WO2018202876A1 (en) 2017-05-04 2018-05-04 Secretion-competent muteins of the human il-27 alpha-subunit

Publications (2)

Publication Number Publication Date
AU2018262811A1 AU2018262811A1 (en) 2019-12-19
AU2018262811B2 true AU2018262811B2 (en) 2021-10-21

Family

ID=58669684

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2018262811A Active AU2018262811B2 (en) 2017-05-04 2018-05-04 Secretion-competent muteins of the human IL-27 alpha-subunit

Country Status (7)

Country Link
US (1) US11358998B2 (enExample)
EP (1) EP3619228A1 (enExample)
JP (1) JP7249955B2 (enExample)
CN (1) CN110709413B (enExample)
AU (1) AU2018262811B2 (enExample)
CA (1) CA3060219A1 (enExample)
WO (1) WO2018202876A1 (enExample)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3955955B1 (en) 2019-04-19 2025-02-26 Synerkine Pharma B.V. A fusion protein comprising il13
JP2023501515A (ja) * 2019-11-12 2023-01-18 テクニッシェ ウニヴェルズィテート ミュンヘン ヒトＩＬ－２７αサブユニットの均質ムテイン
WO2024213695A1 (en) * 2023-04-14 2024-10-17 Technische Universitaet Muenchen Method for producing the subunits of human interleukin 35 from interleukin 12 and interleukin 27
CN116832146B (zh) * 2023-06-30 2024-02-13 广东暨安特博生物科技有限公司 Il-27蛋白在制备治疗阿尔茨海默症的产品的应用
WO2025140436A1 (zh) * 2023-12-27 2025-07-03 上海药明生物技术有限公司 重组il-27蛋白及其制备方法

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4839434B2 (ja) * 2005-03-14 2011-12-21 千葉県 ｐ２８分子またはその遺伝子を含む医薬製剤
HK1206764A1 (en) * 2012-03-26 2016-01-15 Axcella Health Inc. Nutritive proteins and methods

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
JASON S STUMHOFER ET AL, "A role for IL-27p28 as an antagonist of gp130-mediated signaling", NATURE IMMUNOLOGY, (2010-11-07), vol. 11, no. 12, doi:10.1038/ni.1957, ISSN 1529-2908, pages 1119 - 1126 *
OSAMU SHIMOZATO ET AL, "The secreted form of p28 subunit of interleukin (IL)-27 inhibits biological functions of IL-27 and suppresses anti-allogeneic immune responses", IMMUNOLOGY, GB, (2009-09-01), vol. 128, no. 1pt2, pages e816 - e825 *
PFLANZ S ET AL, "IL-27 a heterodimetric cytokine composed of EB13 and p28 protein, induces proliferation of native CD4+ T cells", IMMUNITY, CELL PRESS, US, (2002-06-01), vol. 16, pages 779 - 790 *

Also Published As

Publication number Publication date
CN110709413A (zh) 2020-01-17
US20200062817A1 (en) 2020-02-27
WO2018202876A1 (en) 2018-11-08
US11358998B2 (en) 2022-06-14
CN110709413B (zh) 2023-11-28
EP3619228A1 (en) 2020-03-11
JP2020518249A (ja) 2020-06-25
AU2018262811A1 (en) 2019-12-19
CA3060219A1 (en) 2018-11-08
JP7249955B2 (ja) 2023-03-31

Similar Documents

Publication Publication Date Title
AU2018262811B2 (en) Secretion-competent muteins of the human IL-27 alpha-subunit
Jones et al. Distinct subunit pairing criteria within the heterodimeric IL-12 cytokine family
JPH10502810A (ja) Ｌｅｒｋ−５と命名された新規のサイトカイン
Liu et al. Release of the neuregulin functional polypeptide requires its cytoplasmic tail
Guo et al. Protection against Th17 cells differentiation by an interleukin-23 receptor cytokine-binding homology region
JPH09508009A (ja) Ｆａｓ抗原を結合するリガンド
Müller et al. An interspecies analysis reveals molecular construction principles of interleukin 27
JP6000130B2 (ja) 新規なシグナルペプチドおよび組換えタンパク質の生成のためのその使用
US8658423B2 (en) Insulin-like growth factor II (IGF-II) binding factors
JP7751581B2 (ja) Ｉｌ－３７融合タンパク質及びその使用
JP6320973B2 (ja) Ｂ細胞活性化因子の拮抗物質、その調製方法及び利用法
Huys et al. A subfamily of acidic α-K+ toxins
Darabi et al. Codon optimization, cloning and expression of the human Leukemia Inhibitory Factor (hLIF) in E. coli
Breen et al. Partial sequence of the rat heavy neurofilament polypeptide (NF‐H) Identification of putative phosphorylation sites
US20220380426A1 (en) Homogeneous muteins of the human il-27 alpha-subunit
Kitamura et al. CD45‐associated protein is a lymphocyte‐specific membrane protein expressed in two distinct forms
Monteilhet et al. Cytoplasmic and periplasmic production of human apolipoprotein E in Escherichia coli using natural and bacterial signal peptides
US6537781B1 (en) Methods and compositions concerning canine interleukin 5
Klepp et al. Production of functional bovine IL-22 in a mammalian episomal expression system
Müller Folding and quality control of the interleukin 12 family cytokines interleukin 27 and interleukin 35
WO2025252853A1 (en) Fusion-polypeptide comprising a mutein of the alpha-subunit of human il-27 and at least one pharmaceutically acceptable fusion partner
Pamela Investigation into the Molecular Biology of Human Genetic Sensory Disorders of Painlessness and Itch
WO2024213695A1 (en) Method for producing the subunits of human interleukin 35 from interleukin 12 and interleukin 27
Allen Structure, function and phylogeny of zinc-α2-glycoprotein in health and disease
Ratcliff Characterisation of Prodomains in the GDNF Family

Legal Events

Date Code Title Description
FGA Letters patent sealed or granted (standard patent)